Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT04287452
Other study ID # 001968358
Secondary ID
Status Withdrawn
Phase N/A
First received
Last updated
Start date March 1, 2022
Est. completion date December 31, 2022

Study information

Verified date July 2023
Source Indiana University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Prior literature demonstrates that human stress can be reduced with exposure to animals. This study challenges current dogma by introducing a widely available, low cost method of dog therapy to reduce patient and provider stress. The objectives of this study are to determine if interaction with a certified therapy dog and handler can; - decrease reported anxiety levels in emergency department (ED) patients, - decrease salivary cortisol in ED patients, - decrease total morphine equivalent dosing in the emergency department or at discharge and/or, - decrease reported stress levels in emergency department providers caring for participating patients when compared to usual care.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date December 31, 2022
Est. primary completion date December 31, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: Patients - Age 18-89 years - Chronic pain, defined as pain on most days for >6 weeks - Triage pain score >6 out of 10 OR - Age 18-89 years - Currently experience crisis, including suicidality, or - Meet the standard of a provider assessment of "severe stress" defined by their identification that the patient meets a score of greater than six on the FACES stress scale Providers • Faculty, residents, advanced practitioners, and nurses who work in the ED and identify themselves as being the nurse or physician of record for the enrolled patients. Therapy Dog Handlers • Handler of a certified therapy dog and volunteer of Eskenazi's Therapy Dog Program Exclusion Criteria: Patients - Violent behavior - Overt intoxication - Non-English speaking - Any reported prior fear or adverse reaction to dogs Providers • Any reported prior fear or adverse reaction to dogs Therapy Dog Handlers • None

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Control
Control
Dog Therapy
Exposure to certified therapy dogs and their handler.

Locations

Country Name City State
United States Eskenazi Health System Indianapolis Indiana

Sponsors (2)

Lead Sponsor Collaborator
Indiana University Healthcare Initiatives, Inc.

Country where clinical trial is conducted

United States, 

References & Publications (7)

Barker SB, Dawson KS. The effects of animal-assisted therapy on anxiety ratings of hospitalized psychiatric patients. Psychiatr Serv. 1998 Jun;49(6):797-801. doi: 10.1176/ps.49.6.797. — View Citation

Braun C, Stangler T, Narveson J, Pettingell S. Animal-assisted therapy as a pain relief intervention for children. Complement Ther Clin Pract. 2009 May;15(2):105-9. doi: 10.1016/j.ctcp.2009.02.008. Epub 2009 Mar 3. — View Citation

Havey J, Vlasses F, Vlasses P, Ludwig P, Hackbarth D. The Effect of Animal-Assisted Therapy on Pain Medication Use After Joint Replacement. Anthrozoos 2014; 27: 361-369.

Kelm Z, Womer J, Walter JK, Feudtner C. Interventions to cultivate physician empathy: a systematic review. BMC Med Educ. 2014 Oct 14;14:219. doi: 10.1186/1472-6920-14-219. — View Citation

Marcus DA, Bernstein CD, Constantin JM, Kunkel FA, Breuer P, Hanlon RB. Impact of animal-assisted therapy for outpatients with fibromyalgia. Pain Med. 2013 Jan;14(1):43-51. doi: 10.1111/j.1526-4637.2012.01522.x. Epub 2012 Nov 21. — View Citation

Munoz Lasa S, Maximo Bocanegra N, Valero Alcaide R, Atin Arratibel MA, Varela Donoso E, Ferriero G. Animal assisted interventions in neurorehabilitation: a review of the most recent literature. Neurologia. 2015 Jan-Feb;30(1):1-7. doi: 10.1016/j.nrl.2013.01.012. Epub 2013 May 1. English, Spanish. — View Citation

Smith DD, Kellar J, Walters EL, Reibling ET, Phan T, Green SM. Does emergency physician empathy reduce thoughts of litigation? A randomised trial. Emerg Med J. 2016 Aug;33(8):548-52. doi: 10.1136/emermed-2015-205312. Epub 2016 Mar 21. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Morphine equivalent narcotic administration in emergency department patients with chronic pain Total morphine equivalent narcotic administration while in the emergency department or as a discharge prescription will be recorded for enrolled patients. Date of enrollment until emergency department discharge, up to 72 hours
Primary Change in reported stress levels in ED patients with chronic pain using Wong-Baker FACES Scale (10 = worst) Change in self reported stress levels of emergency department patients using a Wong-Baker FACES Scale for anxiety between baseline and T1 Baseline and T1 (~45 minutes after baseline)
Primary Change in salivary cortisol in ED patients with chronic pain Change in salivary cortisol levels in emergency department patients between baseline and T1 Baseline and T1 (~45 minutes after baseline)
Primary Number of narcotic, sedative and/or neuroleptic doses administered in ED patients with emotional crisis Number of narcotic, sedative and/or neuroleptic doses administered in ED patients with emotional crisis Date of enrollment until emergency department discharge, up to 72 hours
Primary Change in reported stress levels in ED patients with emotional crisis using Wong-Baker FACES Scale (10 = worst) Change in self reported stress levels of emergency department patients using a Wong-Baker FACES Scale for anxiety between baseline and T1 Baseline and T1 (~45 minutes after baseline)
Primary Change in salivary cortisol in ED patients with emotional crisis Change in salivary cortisol levels in emergency department patients between baseline and T1 Baseline and T1 (~45 minutes after baseline)
Secondary Change in salivary cortisol levels in emergency department patients Change in salivary cortisol levels in emergency department patients between baseline and T1 Baseline and T1 (~45 minutes after baseline)
See also
  Status Clinical Trial Phase
Completed NCT01659073 - Using Perfusion MRI to Measure the Dynamic Changes in Neural Activation Associated With Caloric Vestibular Stimulation N/A
Recruiting NCT05914311 - Use of Dermabond in Mitigation of Spinal Cord Stimulation (SCS) Trial Lead Migration N/A
Recruiting NCT05422456 - The Turkish Version of Functional Disability Inventory
Enrolling by invitation NCT05422443 - The Turkish Version of Pain Coping Questionnaire
Completed NCT05057988 - Virtual Empowered Relief for Chronic Pain N/A
Completed NCT04385030 - Neurostimulation and Mirror Therapy in Traumatic Brachial Plexus Injury N/A
Recruiting NCT06206252 - Can Medical Cannabis Affect Opioid Use?
Completed NCT05103319 - Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions
Completed NCT03687762 - Back on Track to Healthy Living Study N/A
Completed NCT04171336 - Animal-assisted Therapy for Children and Adolescents With Chronic Pain N/A
Completed NCT03179475 - Targin® for Chronic Pain Management in Patients With Spinal Cord Injury Phase 4
Completed NCT03418129 - Neuromodulatory Treatments for Pain Management in TBI N/A
Completed NCT03268551 - MEMO-Medical Marijuana and Opioids Study
Recruiting NCT06204627 - TDCS* and Laterality Trainnning in Patients With Chronic Neck Pain N/A
Recruiting NCT06060028 - The Power of Touch. Non-Invasive C-Tactile Stimulation for Chronic Osteoarthritis Pain N/A
Completed NCT05496205 - A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers Phase 1
Completed NCT00983385 - Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics Phase 3
Recruiting NCT05118204 - Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization Phase 4
Terminated NCT03538444 - Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder N/A
Not yet recruiting NCT05812703 - Biometrics and Self-reported Health Changes in Adults Receiving Behavioral Treatments for Chronic Pain